Khanyk Nataliia, Hromovyk Bohdan, Levytska Oksana, Agh Tamas, Wettermark Björn, Kardas Przemyslaw
Uppsala Universitet, Uppsala, Sweden.
Danylo Halytsky Lviv, National Medical University, Lviv, Ukraine.
Front Pharmacol. 2022 Nov 24;13:1024046. doi: 10.3389/fphar.2022.1024046. eCollection 2022.
Due to the Russian invasion, which started on 24 February 2022, the Ukrainian healthcare system is facing multiple challenges. A great number of healthcare facilities have been destroyed, while availability of other ones is often limited due to a lack of qualified medical staff. Certain services, e.g. cancer therapies, have been seriously disrupted. Moreover, millions of Ukrainians with chronic conditions are also suffering as due to war-related problems with execution of their long-term therapies. Availability of drugs is particularly limited in the occupied regions. According to the national statistics, as of 18 August 2022, about 505 pharmacies were damaged in Eastern Ukraine and 47 completely ruined. Moreover, the invaders have been blocking humanitarian aid provided to these territories by the Ukrainian government or other countries. Fortunately, in the areas controlled by the Government of Ukraine, the acute shortage of medicines, observed at the beginning of the war, has already been eliminated. Nevertheless, not all drugs are now fully available, even in the areas where no military attacks occur. The economic availability of drugs is also profoundly influenced by the significant increase in the cost of medications and the fall in average salaries. The Government of Ukraine is trying to minimise the impact of these war-related challenges by adopting a new legislation. This includes, among others, simplification of procedures for licensing, quality control and import of medicinal products to Ukraine. Other measures involve securing displaced people with the option of benefiting from local healthcare facilities, broadening the scope of the ePrescription system, authorizing primary care doctors to issue prescriptions to refugees, increasing the number of drugs reimbursed for long-term therapies, These solutions, however, cannot balance all the harmful consequences the war in Ukraine brings in terms of maintenance of long-term therapies. Therefore, in order to minimise this negative impact, Ukraine still needs urgent international support in this area.
由于2022年2月24日开始的俄罗斯入侵，乌克兰医疗系统面临多重挑战。大量医疗设施被摧毁，而其他一些设施由于缺乏合格医务人员，其可用性往往受到限制。某些服务，如癌症治疗，已受到严重干扰。此外，数百万患有慢性病的乌克兰人也在受苦，因为长期治疗的执行出现了与战争相关的问题。在被占领地区，药品供应尤其有限。根据国家统计，截至2022年8月18日，乌克兰东部约505家药店受损，47家完全被毁。此外，入侵者一直在阻止乌克兰政府或其他国家向这些地区提供人道主义援助。幸运的是，在乌克兰政府控制的地区，战争初期出现的药品严重短缺问题已经消除。然而，即使在没有军事攻击的地区，现在也并非所有药品都能完全供应。药品的经济可及性也受到药品成本大幅上涨和平均工资下降的深刻影响。乌克兰政府正试图通过制定新立法来尽量减少这些与战争相关的挑战的影响。这包括简化药品许可、质量控制和进口到乌克兰的程序等。其他措施包括确保流离失所者能够利用当地医疗设施，扩大电子处方系统的范围，授权初级保健医生为难民开处方，增加长期治疗报销药品的数量。然而，这些解决方案无法平衡乌克兰战争在长期治疗维持方面带来的所有有害后果。因此，为了尽量减少这种负面影响，乌克兰在这一领域仍急需国际支持。
